All Stories

  1. Use of adjuvants to make neonatal vaccines more effective

    Article • Expert Review of Clinical Immunology, July 2019, Taylor & Francis

    Professor Nikolai Petrovsky

  2. Advax4 delta inulin combination adjuvant together with ECMX, a fusion construct of four protective mTB antigens, induces a potent Th1 immune response and protects mice against Mycobacterium tuberculosis infection

    Article • Human Vaccines & Immunotherapeutics, September 2017, Taylor & Francis

    Professor Ana Paula Junqueira Kipnis, Professor Nikolai Petrovsky, Prof. Dr. Mara Rubia N Celes

  3. Inulin crystal initiation via a glucose-fructose cross-link of adjacent polymer chains: Atomic force microscopy and static molecular modelling

    Article • Carbohydrate Polymers, March 2015, Elsevier

    Professor Nikolai Petrovsky

  4. Pulmonary immunisation

    Article • European Journal of Pharmaceutical Sciences, January 2015, Elsevier

    Professor Nikolai Petrovsky

  5. Severe Acute Respiratory Syndrome-Associated Coronavirus Vaccines Formulated with Delta Inulin Adjuvants Provide Enhanced Protection while Ameliorating Lung Eosinophilic Immunopathology

    Article • Journal of Virology, December 2014, ASM Journals

    Professor Nikolai Petrovsky

  6. Immunogenicity and safety of Advax™, a novel polysaccharide adjuvant based on delta inulin, when formulated with hepatitis B surface antigen: A randomized controlled Phase 1 study

    Article • Vaccine, November 2014, Elsevier

    Professor Nikolai Petrovsky

  7. Editorial (Thematic Issue: The Coming of Age of DNA Vaccines)

    Article • Current Gene Therapy, August 2014, Bentham Science Publishers

    Professor Nikolai Petrovsky

  8. Plasmids Encoding Protein Aggregation Domains Act As Molecular Adjuvants for DNA Vaccines

    Article • Current Gene Therapy, August 2014, Bentham Science Publishers

    Professor Nikolai Petrovsky

  9. A single immunization with inactivated H1N1 influenza vaccine formulated with delta inulin adjuvant (Advax™) overcomes pregnancy-associated immune suppression and enhances passive neonatal protection

    Article • Vaccine, August 2014, Elsevier

    Professor Nikolai Petrovsky

  10. In Silico Structural Homology Modelling and Docking for Assessment of Pandemic Potential of a Novel H7N9 Influenza Virus and Its Ability to Be Neutralized by Existing Anti-Hemagglutinin Antibodies

    Article • PLoS ONE, July 2014, PLOS

    Professor Nikolai Petrovsky

  11. Inulin isoforms differ by repeated additions of one crystal unit cell

    Article • Carbohydrate Polymers, March 2014, Elsevier

    Professor Nikolai Petrovsky

  12. Gamma ray sterilization of delta inulin adjuvant particles (Advax™) makes minor, partly reversible structural changes without affecting adjuvant activity

    Article • Vaccine, January 2014, Elsevier

    Professor Nikolai Petrovsky

  13. Genetic study of diabetic retinopathy: recruitment methodology and analysis of baseline characteristics

    Article • Clinical and Experimental Ophthalmology, October 2013, Wiley

    Professor Nikolai Petrovsky

  14. Chiral Self-Assembly of Designed Amphiphiles: Influences on Aggregate Morphology

    Article • Langmuir, July 2013, American Chemical Society (ACS)

    Professor Nikolai Petrovsky

  15. An Inactivated Cell Culture Japanese Encephalitis Vaccine (JE-ADVAX) Formulated with Delta Inulin Adjuvant Provides Robust Heterologous Protection against West Nile Encephalitis via Cross-Protective Memory B Cells and Neutralizing Antibody

    Article • Journal of Virology, July 2013, ASM Journals

    Professor Nikolai Petrovsky

  16. Pulmonary Hypertension in Chronic Lung Diseases and/or Hypoxia

    Article • July 2013, IntechOpen

    Professor Nikolai Petrovsky, Dr Dimitar Sajkov

  17. Vaccine adjuvants: in search of new paradigms

    Article • Expert Review of Vaccines, July 2013, Taylor & Francis

    Professor Nikolai Petrovsky

  18. Vaccine adjuvant safety: the elephant in the room

    Article • Expert Review of Vaccines, July 2013, Taylor & Francis

    Professor Nikolai Petrovsky

  19. A novel hepatitis B vaccine containing Advax™, a polysaccharide adjuvant derived from delta inulin, induces robust humoral and cellular immunity with minimal reactogenicity in preclinical testing

    Article • Vaccine, April 2013, Elsevier

    Professor Nikolai Petrovsky

  20. Flu watch

    Article • The New Scientist, April 2013, Elsevier

    Professor Nikolai Petrovsky

  21. JE-ADVAX Vaccine Protection against Japanese Encephalitis Virus Mediated by Memory B Cells in the Absence of CD8+ T Cells and Pre-Exposure Neutralizing Antibody

    Article • Journal of Virology, February 2013, ASM Journals

    Professor Nikolai Petrovsky

  22. Systems Immunology, Vaccine Adjuvant

    Article • January 2013, Springer Science + Business Media

    Professor Nikolai Petrovsky

  23. Unconventional Vaccines: Progress and Challenges

    Article • Journal of Vaccines & Vaccination, January 2013, OMICS Publishing Group

    Professor Nikolai Petrovsky

  24. A randomized controlled study to assess the immunogenicity and tolerability of a 2012 trivalent seasonal inactivated influenza vaccine administered via a disposable syringe jet injector device versus a traditional pre-filled syringe and needle

    Article • Trials in Vaccinology, January 2013, Elsevier

    Professor Nikolai Petrovsky, Dr Dimitar Sajkov

  25. The future of human DNA vaccines

    Article • Journal of Biotechnology, December 2012, Elsevier

    Professor Nikolai Petrovsky

  26. Pushing the frontiers of T-cell vaccines: accurate measurement of human T-cell responses

    Article • Expert Review of Vaccines, December 2012, Taylor & Francis

    Professor Nikolai Petrovsky

  27. BBS-Induced Ciliary Defect Enhances Adipogenesis, Causing Paradoxical Higher-Insulin Sensitivity, Glucose Usage, and Decreased Inflammatory Response

    Article • Cell Metabolism, September 2012, Elsevier

    Professor Nikolai Petrovsky

  28. Randomized clinical trial of immunogenicity and safety of a recombinant H1N1/2009 pandemic influenza vaccine containing Advax™ polysaccharide adjuvant

    Article • Vaccine, August 2012, Elsevier

    Professor Nikolai Petrovsky, Dr Dimitar Sajkov

  29. Advax™, a polysaccharide adjuvant derived from delta inulin, provides improved influenza vaccine protection through broad-based enhancement of adaptive immune responses

    Article • Vaccine, August 2012, Elsevier

    Professor Nikolai Petrovsky

  30. Report from the field

    Article • Human Vaccines & Immunotherapeutics, July 2012, Taylor & Francis

    Professor Nikolai Petrovsky

  31. Analysis of the hydrolysis of inulin using real time 1H NMR spectroscopy

    Article • Carbohydrate Research, May 2012, Elsevier

    Professor Nikolai Petrovsky

  32. Relationship between DDAH gene variants and serum ADMA level in individuals with type 1 diabetes

    Article • Journal of Diabetes and its Complications, May 2012, Elsevier

    Professor Nikolai Petrovsky

  33. Technologies for enhanced efficacy of DNA vaccines

    Article • Expert Review of Vaccines, February 2012, Taylor & Francis

    Professor Nikolai Petrovsky

  34. Observation of the keto tautomer of d-fructose in D2O using 1H NMR spectroscopy

    Article • Carbohydrate Research, January 2012, Elsevier

    Professor Nikolai Petrovsky

  35. Dyspnea in Pulmonary Arterial Hypertension

    Article • December 2011, IntechOpen

    Professor Nikolai Petrovsky, Dr Dimitar Sajkov

  36. Delta inulin polysaccharide adjuvant enhances the ability of split-virion H5N1 vaccine to protect against lethal challenge in ferrets

    Article • Vaccine, August 2011, Elsevier

    Professor Nikolai Petrovsky

  37. Pediatric influenza immunization

    Article • Expert Review of Vaccines, May 2011, Taylor & Francis

    Professor Nikolai Petrovsky, Dr Dimitar Sajkov

  38. Serological responses following influenza A H1N1 2009 infection in adults

    Article • Journal of Infection, May 2011, Elsevier

    Professor Nikolai Petrovsky

  39. Carbohydrate-based immune adjuvants

    Article • Expert Review of Vaccines, April 2011, Taylor & Francis

    Professor Nikolai Petrovsky

  40. The Vaccine Renaissance

    Article • Human Vaccines, February 2011, Taylor & Francis

    Professor Nikolai Petrovsky

  41. Challenges in improving influenza vaccine protection in the elderly

    Article • Expert Review of Vaccines, January 2011, Taylor & Francis

    Professor Nikolai Petrovsky

  42. World Vaccine Congress Asia 2011 (June 20-24, 2011, Singapore)

    Article • Drugs of the Future, January 2011, Prous Science

    Professor Nikolai Petrovsky

  43. Alström syndrome: insights into the pathogenesis of metabolic disorders

    Article • Nature Reviews Endocrinology, December 2010, Springer Science + Business Media

    Professor Nikolai Petrovsky, Dorothee Girard

  44. Lessons learned from the H1N1 2009 pandemic

    Article • Human Vaccines, October 2010, Taylor & Francis

    Professor Nikolai Petrovsky

  45. Management of dyspnea in advanced pulmonary arterial hypertension

    Article • Current Opinion in Supportive and Palliative Care, June 2010, Wolters Kluwer Health

    Professor Nikolai Petrovsky, Dr Dimitar Sajkov

  46. Immunomodulation with microbial vaccines to prevent type 1 diabetes mellitus

    Article • Nature Reviews Endocrinology, March 2010, Springer Science + Business Media

    Professor Nikolai Petrovsky

  47. Sequence Variation in DDAH1 and DDAH2 Genes Is Strongly and Additively Associated with Serum ADMA Concentrations in Individuals with Type 2 Diabetes

    Article • PLoS ONE, March 2010, PLOS

    Professor Nikolai Petrovsky

  48. Focus on Influenza vaccines

    Article • Human Vaccines, October 2009, Taylor & Francis

    Professor Nikolai Petrovsky

  49. Pharmacological Management of Endocrine Conditions in the Elderly Patient

    Article • April 2009, Wiley

    Professor Nikolai Petrovsky

  50. AFCo1, a meningococcal B-derived cochleate adjuvant, strongly enhances antibody and T-cell immunity against Plasmodium falciparum merozoite surface protein 4 and 5

    Article • Malaria Journal, February 2009, Springer Science + Business Media

    Professor Nikolai Petrovsky

  51. 4-Hydroxydocosahexaenoic acid, a potent peroxisome proliferator-activated receptor γ agonist alleviates the symptoms of DSS-induced colitis

    Article • Biochemical and Biophysical Research Communications, March 2008, Elsevier

    Professor Nikolai Petrovsky

  52. Freeing vaccine adjuvants from dangerous immunological dogma

    Article • Expert Review of Vaccines, February 2008, Taylor & Francis

    Professor Nikolai Petrovsky

  53. Data Extraction for Improved Prediction Outcomes in Organ Transplantation — A Hybrid Approach

    Article • October 2006, World Scientific Pub Co Pte Lt

    Professor Nikolai Petrovsky

  54. Fat Aussie—A New Alström Syndrome Mouse Showing a Critical Role for ALMS1 in Obesity, Diabetes, and Spermatogenesis

    Article • Molecular Endocrinology, July 2006, Endocrine Society

    Professor Nikolai Petrovsky

  55. Novel human polysaccharide adjuvants with dual Th1 and Th2 potentiating activity

    Article • Vaccine, April 2006, Elsevier

    Professor Nikolai Petrovsky

  56. Adaptive failure to high-fat diet characterizes steatohepatitis in Alms1 mutant mice

    Article • Biochemical and Biophysical Research Communications, April 2006, Elsevier

    Professor Nikolai Petrovsky

  57. Bioinformatics for study of autoimmunity

    Article • Autoimmunity, January 2006, Taylor & Francis

    Professor Nikolai Petrovsky

  58. PREDNOD, a prediction server for peptide binding to the H-2g7haplotype of the non-obese diabetic mouse

    Article • Autoimmunity, January 2006, Taylor & Francis

    Professor Nikolai Petrovsky

  59. Type 1 Diabetes: Immunology and Genetics

    Article • January 2006, Elsevier

    Professor Nikolai Petrovsky

  60. Temporal regulation of the human immune system

    Article • Expert Review of Clinical Immunology, September 2005, Taylor & Francis

    Professor Nikolai Petrovsky

  61. Assessment of cardiovascular disease risk factors and diabetes mellitus in Australian prisons: is the prisoner population unhealthier than the rest of the Australian population?

    Article • Australian and New Zealand Journal of Public Health, August 2005, Elsevier

    Professor Nikolai Petrovsky

  62. Information technologies for vaccine research

    Article • Expert Review of Vaccines, June 2005, Taylor & Francis

    Professor Nikolai Petrovsky

  63. Immunoinformatics and its relevance to understanding human immune disease

    Article • Expert Review of Clinical Immunology, May 2005, Taylor & Francis

    Professor Nikolai Petrovsky

  64. Hypothyroidism and hyponatraemia in the hospital setting

    Article • Pathology, April 2005, Elsevier

    Professor Nikolai Petrovsky

  65. Dexamethasone Infusion Testing in the Diagnosis of Cushing's Syndrome

    Article • Endocrine Journal, January 2005, Japan Endocrine Society

    Professor Nikolai Petrovsky

  66. A Hybrid Decision Tree – Artificial Neural Networks Ensemble Approach for Kidney Transplantation Outcomes Prediction

    Article • January 2005, Springer Science + Business Media

    Professor Nikolai Petrovsky

  67. Virtual models of the HLA class I antigen processing pathway

    Article • Methods, December 2004, Elsevier

    Professor Nikolai Petrovsky

  68. Identification of Key β Cell Gene Signaling Pathways Involved in Type 1 Diabetes

    Article • Annals of the New York Academy of Sciences, December 2004, Wiley

    Professor Nikolai Petrovsky

  69. The Power of an Integrated Informatic and Molecular Approach to Type 1 Diabetes Research

    Article • Annals of the New York Academy of Sciences, December 2004, Wiley

    Professor Nikolai Petrovsky

  70. Addison's disease presenting in four adolescents with type 1 diabetes

    Article • Pediatric Diabetes, December 2004, Hindawi Publishing Corporation

    Professor Nikolai Petrovsky

  71. Computational methods for prediction of T-cell epitopes—a framework for modelling, testing, and applications

    Article • Methods, December 2004, Elsevier

    Professor Nikolai Petrovsky

  72. Inulin‐derived adjuvants efficiently promote both Th1 and Th2 immune responses

    Article • Immunology and Cell Biology, December 2004, Wiley

    Professor Nikolai Petrovsky

  73. Elevated Lymphocyte Expression of CLIP Is Associated with Type 1 Diabetes and May Be a Useful Marker of Autoimmune Susceptibility

    Article • Annals of the New York Academy of Sciences, December 2004, Wiley

    Professor Nikolai Petrovsky

  74. A rash: Part 1

    Article • Pathology, December 2004, Elsevier

    Professor Nikolai Petrovsky

  75. Vaccine adjuvants: Current state and future trends

    Article • Immunology and Cell Biology, September 2004, Wiley

    Professor Nikolai Petrovsky

  76. The perils of untimed serum cortisol measurement

    Article • Pathology, June 2004, Elsevier

    Professor Nikolai Petrovsky

  77. A swollen abdomen: Part 1

    Article • Pathology, April 2004, Elsevier

    Professor Nikolai Petrovsky

  78. VIRAL ENCEPHALITIS IN HUMANS

    Article • Immunology and Cell Biology, February 2004, Wiley

    Professor Nikolai Petrovsky

  79. Use of Artificial Neural Networks in the Prediction of Kidney Transplant Outcomes

    Article • January 2004, Springer Science + Business Media

    Professor Nikolai Petrovsky

  80. Autoimmune Diabetes in the NOD Mouse: An Essential Role of Fas‐FasL Signaling in β Cell Apoptosis

    Article • Annals of the New York Academy of Sciences, November 2003, Wiley

    Professor Nikolai Petrovsky

  81. Macrophage migration inhibitory factor exhibits a pronounced circadian rhythm relevant to its role as a glucocorticoid counter‐regulator

    Article • Immunology and Cell Biology, April 2003, Wiley

    Professor Nikolai Petrovsky

  82. Vaccine Therapies for the Prevention of Type 1 Diabetes Mellitus

    Article • Pediatric Drugs, January 2003, Springer Science + Business Media

    Professor Nikolai Petrovsky

  83. Evidence from twins for acquired cellular immune hyperactivity in type 1 diabetes

    Article • Immunology, August 2002, Wiley

    Professor Nikolai Petrovsky

  84. Computational immunology: The coming of age

    Article • Immunology and Cell Biology, June 2002, Wiley

    Professor Nikolai Petrovsky

  85. Prediction of promiscuous peptides that bind HLA class I molecules

    Article • Immunology and Cell Biology, June 2002, Wiley

    Professor Nikolai Petrovsky

  86. Prospects for the Prevention and Reversal of Type 1 Diabetes Mellitus

    Article • Drugs, January 2002, Springer Science + Business Media

    Professor Nikolai Petrovsky

  87. Use of Artificial Neural Networks in Improving Renal Transplantation Outcomes

    Article • Graft, January 2002, Portico

    Professor Nikolai Petrovsky

  88. Efficient discovery of immune response targets by cyclical refinement of QSAR models of peptide binding

    Article • Journal of Molecular Graphics and Modelling, October 2001, Elsevier

    Professor Nikolai Petrovsky, Prof John Zeleznikow

  89. Towards a unified model of neuroendocrine–immune interaction

    Article • Immunology and Cell Biology, August 2001, Wiley

    Professor Nikolai Petrovsky

  90. Molecular immunology databases and data repositories

    Article • Journal of Immunological Methods, April 2000, Elsevier

    Professor Nikolai Petrovsky, Prof John Zeleznikow

  91. Macrophage Migration Inhibitory Factor (MIF): A Critical Neurohumoral Mediator

    Article • Annals of the New York Academy of Sciences, January 2000, Wiley

    Professor Nikolai Petrovsky

  92. DIURNAL RHYTHMS OF PRO-INFLAMMATORY CYTOKINES: REGULATION BY PLASMA CORTISOL AND THERAPEUTIC IMPLICATIONS

    Article • Cytokine, April 1998, Elsevier

    Professor Nikolai Petrovsky

  93. The Chronobiology of Human Cytokine Production

    Article • International Reviews of Immunology, January 1998, Taylor & Francis

    Professor Nikolai Petrovsky

  94. HLA Class II-associated polymorphism of interferon-γ production implications for HLA-disease association

    Article • Human Immunology, March 1997, Elsevier

    Professor Nikolai Petrovsky

  95. Evidence for the Viral Aetiology of IDDM

    Article • Autoimmunity, January 1997, Taylor & Francis

    Professor Nikolai Petrovsky

  96. The paradoxical association between immunodeficiency and autoimmunity: Comment on he article by Atkinson

    Article • Arthritis & Rheumatism, January 1996, Wiley

    Professor Nikolai Petrovsky

  97. Th1 and Th2: swinging to a hormonal rhythm

    Article • Immunology Today, December 1995, Elsevier

    Professor Nikolai Petrovsky

  98. Cytokine-based human whole blood assay for the detection of antigen-reactive T cells

    Article • Journal of Immunological Methods, October 1995, Elsevier

    Professor Nikolai Petrovsky

  99. T-cell receptor signal sequences

    Article • Immunology Today, August 1995, Elsevier

    Professor Nikolai Petrovsky

  100. Difficulties and dangers of vaccination strategies for asthma and other autoimmune disorders

    Article • The Lancet, October 1994, Elsevier

    Professor Nikolai Petrovsky

  101. Whole Blood Assays and the Influence of Circadian Rhythmicity on Human Cytokine Measurement

    Article • Springer Science + Business Media

    Professor Nikolai Petrovsky

  102. Immunoinformatics—The New Kid in Town

    Article • Wiley

    Professor Nikolai Petrovsky

  103. Use of Artificial Neural Networks in Improving Renal Transplantation Outcomes

    Article • Graft, Portico

    Professor Nikolai Petrovsky

  104. The Future for Computational Modelling and Prediction Systems in Clinical Immunology

    Article • Wiley

    Professor Nikolai Petrovsky